Mitra® devices with VAMS® technology simplify remote specimen collection and microsampling, with formats that fit every budget.
Request PricingTake specimen collection out of the facility for new opportunities with sampling at home and beyond borders for decentralized clinical research with easier recruitment and improved adherence. Remotely collect precise, volumetric specimens from diverse populations with greater ease and high sampling success rates. Eliminate both reliance on trained staff for specimen collection and costly cold-chain storage and shipping. Process dried Mitra specimens in high-throughput workflows to generate quantitative data.
Validate Mitra Devices for Your Microsampling Initiatives
This simple device provides an economical way for you to get started with microsampling for bioanalytical, operational, and end-user validations.
Build Your Own Kits or Sample Large Cohorts Remotely
With this format you can collect many samples in the field and ship them back to the lab in bulk. You may prefer to insert them into your own all-in-one kit.
All-in-one Solution for Remote Specimen Collection
Our Mitra devices can be packed in convenient kits with sterile components for safe sample collection. Kits can be shipped to your end-users.
Accession & Process Multiple Mitra Samples at Once
This high-throughput solution allows you to rapidly process Mitra microsamples for method development, plate building, extractions - or all of the above!
Complete our simple form and an experienced Microsampling Specialist will guide you through the Mitra device selection process in order to tailor the format / pricing to your unique project needs and budget.
The Mitra device is not sold as a sterile product.
Evaluation devices are available on a case-by-case basis. A Neoteryx Microsampling Specialist will review the options with you during your initial project meeting.
Dried specimen Mitra samples are compatible with common lab instrumentation, including but not limited to liquid-handling workstations, LC-MS/MS, ELISA, Multi-Plex Immunoassays, and other analyzers.
The Mitra device does not contain any stabilizing agents.
Yes, we can customize the Mitra device formats and collection kits to your needs. This may include additional barcodes, custom instructions, or other details specific to your project. Please ask about available customizations during your meeting with a Neoteryx Microsampling Specialist.
Our microsampling devices are produced at Trajan's Center of Excellence in Malaysia and shipped to you from our regional distribution centers in the USA, Australia and the United Kingdom. Shipment lead times are dependent upon order volume but, typically, orders ship within 7-10 business days after we receive your purchase order. We encourage you to follow up with your Microsampling Specialist to help you track your order through the shipment process.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine. In the USA, Mitra devices are supplied as a Research Use Only (RUO) product to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements. .
Our standard collection kit includes a Mitra device packed in a specimen bag with a sachet of drying desiccant, instructions for use, other supplies needed for safe remote sample collection, and a return envelope for mailing samples to the lab. Ask your Microsampling Specialist how kits may be customized per your project needs.
There are three options to purchase Mitra devices. You can pay by credit card, invoice or proforma invoice (prepay by wire transfer).
We sell direct to most countries globally with the exception of a few countries, where we work with authorized distributors. Please contact us for country-specific details.
Complete the form by clicking the button below and an experienced Microsampling Specialist will guide you through the Mitra device selection process in order to tailor the format / pricing to your unique project needs and budget.
VAMS technology allows convenient at-home monitoring and is minimally invasive. It also offers efficiencies in research settings."
Dr. Christophe Stove, Ghent University, Belgium
Mitra with VAMS technology offers simplicity and rapidity of use, while maintaining high performance and guaranteeing reliable data."
Dr. Laura Mercolini, University of Bologna, Italy
With a small fingerprick, study volunteers can use the Mitra devices to help scientists fight COVID-19 from their homes."
Dr. Kaitlyn Sadtler, National Institutes of Health (NIH), US
Contact Us
Trajan Scientific Americas Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of blood. They are CE-IVD in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada and Ukraine.
In the USA, Mitra devices are supplied as a Research-Use Only (RUO) product, to assist in method development, other research-related and non-diagnostic activities. Mitra has not been validated for use with any diagnostic testing. The suitability of Mitra for any analytical application must be evaluated and validated by the laboratory or research institute in a manner consistent with local regulatory requirements.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
Mitra®, VAMS® & hemaPEN® are registered trademarks owned by entities in the Trajan Group.
Copyright © 2022. All rights reserved.